About us
Vision & Mission
C4Diagnostics is developing in vitro diagnostics kits based on its proprietary technology, with the following specifications in mind:
Simple for the lab, fast and accurate for the patient and the medical community: actionable medical information for medical professionals.
C4Diagnostics aims at disrupting the global market of infectious diseases IVD by:
- Delivering faster highly sensitive results
- Addressing unmet medical needs
C4Diagnostics develops and commercializes IVD kits based on its proprietary, versatile, phenotypic and simple technology.
History
Our Commitments
ISO 13485 standards
C4Diagnostics commits to deliver accurate medical information with products designed and manufactured according to the highest standards.
Lloyd’s Registrer (Notified Body) ISO 13485:2016 certified C4Dx in January 2019
Team
C4Diagnostics’ management team has significant and complementary experience in the development, implementation, and commercialization of infectious diseases in vitro diagnostics.
Today, the C4Diagnostics’ team includes 10 full time jobs and of 3 part-time jobs.
Younes Lazrak
Founder & CEO
Before cofounding C4Diagnostics, Younes worked in Business Development and IP management in several in vitro diagnostics companies (Incl. Ipsogen & Qiagen), with an impressive track record. His main responsibilities were Licensing in & out and the management of the industrial intellectual ownership, before progressively shifting to Business development and alliances management.
Émilie Fugier
Founder & Head of R&D
PhD in microbiology and immunology, Emilie has managed various scientific projects involving different pathogenic organisms with industries (CHEMUNEX) and hospitals (CHU Grenoble, Hôpital St-Joseph Marseille). In 2012, she joined Sam Dukan team in the CNRS to work on the technology used by C4Diagnostic. She is now managing the R&D Team composed of 4 persons.
Thierry Maunier
Head of Quality & Regulatory Affairs
Quality Engineer & M.Sc. in Microbiology and Immunology, Thierry served as Quality Assurance and Quality Control Manager in various Medical Device design and manufacturing companies. Quality Systems he implemented and managed have efficiently fulfilled international standards (ISO13485, ISO9001) & International Regulation requirements (MDR, MDIVD, 21CFRs, SOR).
Stéphane Coisne
Head of Marketing & Sales
Stéphane has over twenty years of experience in In Vitro diagnostic field, including in the companies Alere and Astute medical.
Saïd Jamal
Head of Project & Operations
Saïd joined the team in January 2018, as an investor and team member. He brings his organisational experience, developed mostly in the pharmaceutical company GSK, since 2009.
Advisors
Sam Dukan
Founder & Scientific Advisor
Former student of the Ecole Normale Supérieure in Paris, then research director leading a team of up to 12 people in CNRS (National Center of Scientifical research), Sam has worked during his all career within big groups like Suez Environnement or CIBA, on application challenges, witnessing technical and operationnal adaptability. Author of 45 scientific publications and co-inventor of 8 patents, Sam is supervising and scientifically advising the C4Diagnostics projects.
Didier Noël
CFO Part time
Didier goes along C4Diagnostics on daily basis, in the implementation of its organisation and of the finance. Didier’s experience is strong of its 18 years, mainly with Philips, KPMG and the SATT South-Est, where he has follow the C4Diagnostics project origins.
Board
Jean-François GRENIER
Market Access
Strategy advisor – 25+ years exp.
Angels santé (former Bayer, Bristol-Myers Squib)
Hélène PEYRO-ST-PAUL
Medical Affairs
Medical Affairs – 20+ years exp.
Independant (former Qiagen, EMD Serono)
Pascale BOISSEL
Finance
Finance & Administration – 25+ years exp.
Independant (former Ipsogen, Bioaster)
Aurélie VIAUX
Board member
Investment Director – 10 years exp.
Turenne Capital
Jérôme FERAUD
Board member
Investment Director – 14 years exp.
ACG Management
